{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T03:45:31Z","timestamp":1773027931382,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["168284\/2017-0"],"award-info":[{"award-number":["168284\/2017-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/08204-2"],"award-info":[{"award-number":["2016\/08204-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/19145-7"],"award-info":[{"award-number":["2016\/19145-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/20045-7"],"award-info":[{"award-number":["2016\/20045-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/23560-0"],"award-info":[{"award-number":["2016\/23560-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/23281-6"],"award-info":[{"award-number":["2017\/23281-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/24769-2"],"award-info":[{"award-number":["2017\/24769-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.nano.2021.102445","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T19:14:35Z","timestamp":1626981275000},"page":"102445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies"],"prefix":"10.1016","volume":"37","author":[{"given":"Al\u00e9xia Adrianne","family":"Venceslau-Carvalho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Teixeira de Pinho Favaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lennon","family":"Ramos Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f4nica Josiane","family":"Rodrigues-Jesus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Santos Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Andreata-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00fabens Prince","family":"dos Santos Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Fernanda","family":"Castro-Amarante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Bitencourt Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamile","family":"Ramos da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Rahal Guaragna Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marielton","family":"dos Passos Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Marinho de Andrade Zanotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wesley","family":"Luzetti Fotoran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Wunderlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edison Luiz","family":"Durigon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00eds Carlos","family":"de Souza Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2021.102445_bb0005","series-title":"Clinical features","volume":"49","author":"Robinson","year":"1955"},{"key":"10.1016\/j.nano.2021.102445_bb0010","series-title":"The Lancet","article-title":"Chikungunya: a re-emerging virus","author":"Burt","year":"2012"},{"key":"10.1016\/j.nano.2021.102445_bb0015","doi-asserted-by":"crossref","unstructured":"Simon F, Javelle E, Oliver M, Leparc-Goffart I, Marimoutou C. Chikungunya virus infection. Curr Infect Dis Rep [Internet]. 2011 Jun 6 [cited 2019 Oct 25];13(3):218\u201328. Available from: http:\/\/link.springer.com\/10.1007\/s11908-011-0180-1.","DOI":"10.1007\/s11908-011-0180-1"},{"key":"10.1016\/j.nano.2021.102445_bb0020","doi-asserted-by":"crossref","unstructured":"Feldstein LR, Ellis EM, Rowhani-Rahbar A, Hennessey MJ, Staples JE, Halloran ME, et al. Estimating the cost of illness and burden of disease associated with the 2014\u20132015 chikungunya outbreak in the U.S. Virgin Islands. Maheu-Giroux M, editor. PLoS Negl Trop Dis [Internet]. 2019 Jul 19 [cited 2020 May 6];13(7):e0007563. Available from: http:\/\/dx.plos.org\/10.1371\/journal.pntd.0007563.","DOI":"10.1371\/journal.pntd.0007563"},{"key":"10.1016\/j.nano.2021.102445_bb0025","doi-asserted-by":"crossref","unstructured":"Lum FM, Ng LFP. Cellular and molecular mechanisms of chikungunya pathogenesis. Vol. 120, Antiviral Research. Elsevier B.V.; 2015. p. 165\u201374.","DOI":"10.1016\/j.antiviral.2015.06.009"},{"key":"10.1016\/j.nano.2021.102445_bb0030","first-page":"9(4)","article-title":"A small antigenic determinant of the Chikungunya virus E2 protein is sufficient to induce neutralizing antibodies which are partially protective in mice","volume":"23","author":"Weber","year":"2015","journal-title":"PLoS Negl Trop Dis."},{"issue":"4","key":"10.1016\/j.nano.2021.102445_bb0035","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/emmm.201200213","article-title":"Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein","volume":"4","author":"Kam","year":"2012","journal-title":"EMBO Mol Med."},{"key":"10.1016\/j.nano.2021.102445_bb0040","first-page":"9(4)","article-title":"Unique epitopes recognized by antibodies induced in chikungunya virus-infected non-human primates: Implications for the study of immunopathology and vaccine development","volume":"22","author":"Kam","year":"2014","journal-title":"PLoS One."},{"key":"10.1016\/j.nano.2021.102445_bb0045","doi-asserted-by":"crossref","unstructured":"O\u2019Hagan DT, Fox CB. New generation adjuvants \u2014 from empiricism to rational design. Vol. 33, Vaccine. Elsevier Ltd; 2015. p. B14\u201320.","DOI":"10.1016\/j.vaccine.2015.01.088"},{"key":"10.1016\/j.nano.2021.102445_bb0050","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpharm.2008.04.036","article-title":"Vaccine adjuvant systems: Enhancing the efficacy of sub-unit protein antigens","volume":"364","author":"Perrie","year":"2008","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.nano.2021.102445_bb0055","doi-asserted-by":"crossref","unstructured":"Gomes A, Mohsen M, Bachmann M. Harnessing nanoparticles for immunomodulation and vaccines. Vaccines [Internet]. 2017 Feb 14 [cited 2020 May 6];5(1):6. Available from: http:\/\/www.mdpi.com\/2076-393X\/5\/1\/6.","DOI":"10.3390\/vaccines5010006"},{"issue":"9744","key":"10.1016\/j.nano.2021.102445_bb0065","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(10)61030-6","article-title":"Efficacy and safety of a recombinant hepatitis e vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial","volume":"376","author":"Zhu","year":"2010","journal-title":"Lancet."},{"key":"10.1016\/j.nano.2021.102445_bb0075","doi-asserted-by":"crossref","unstructured":"Fotoran WL, M\u00fcntefering T, Kleiber N, Miranda BNM, Liebau E, Irvine DJ, et al. A multilamellar nanoliposome stabilized by interlayer hydrogen bonds increases antimalarial drug efficacy. Nanomedicine Nanotechnology, Biol Med [Internet]. 2019 Oct [cited 2019 Oct 25];102099. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963419301832.","DOI":"10.1016\/j.nano.2019.102099"},{"issue":"1","key":"10.1016\/j.nano.2021.102445_bb0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s42770-018-0035-0","article-title":"Nano-multilamellar lipid vesicles (NMVs) enhance protective antibody responses against Shiga toxin (Stx2a) produced by enterohemorrhagic Escherichia coli strains (EHEC)","volume":"50","author":"Rodrigues-Jesus","year":"2019","journal-title":"Brazilian J Microbiol."},{"key":"10.1016\/j.nano.2021.102445_bb0085","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: current state and future trends","volume":"82","author":"Petrovsky","year":"2004","journal-title":"Immunology and Cell Biology"},{"issue":"19","key":"10.1016\/j.nano.2021.102445_bb0090","doi-asserted-by":"crossref","first-page":"7914","DOI":"10.1073\/pnas.1104588108","article-title":"Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells","volume":"108","author":"MacLeod","year":"2011","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.nano.2021.102445_bb0095","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3488","article-title":"Applications of nanotechnology for immunology","volume":"13","author":"Smith","year":"2013","journal-title":"Nature Reviews Immunology"},{"issue":"2","key":"10.1016\/j.nano.2021.102445_bb0100","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jviromet.2010.04.003","article-title":"Refolded dengue virus type 2 NS1 protein expressed in Escherichia coli preserves structural and immunological properties of the native protein","volume":"167","author":"Amorim","year":"2010","journal-title":"J Virol Methods."},{"key":"10.1016\/j.nano.2021.102445_bb0105","unstructured":"Organisation WH. Guiderlines for plaque reduction neutralization testing of human antibodies to dengue viruses. Geneva WHO [Internet]. 1385."},{"key":"10.1016\/j.nano.2021.102445_bb0110","series-title":"Neutralization assay for chikungunya virus infection: plaque reduction neutralization test","first-page":"273","author":"Azami","year":"2016"},{"key":"10.1016\/j.nano.2021.102445_bb0115","first-page":"7(1)","article-title":"Chikungunya virus infection of cell lines: analysis of the east, central and south African lineage","volume":"27","author":"Wikan","year":"2012","journal-title":"PLoS One."},{"issue":"5","key":"10.1016\/j.nano.2021.102445_bb0120","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4269\/ajtmh.12-0461","article-title":"Optimization and validation of a plaque reduction neutralization test for the detection of neutralizing antibodies to four serotypes of dengue virus used in support of dengue vaccine development","volume":"88","author":"Timiryasova","year":"2013","journal-title":"Am J Trop Med Hyg."},{"key":"10.1016\/j.nano.2021.102445_bb0125","doi-asserted-by":"crossref","unstructured":"Rosano GL, Ceccarelli EA. Recombinant protein expression in Escherichia coli: advances and challenges. Front Microbiol. 2014;5(APR):1\u201317.","DOI":"10.3389\/fmicb.2014.00172"},{"key":"10.1016\/j.nano.2021.102445_bb0130","doi-asserted-by":"crossref","unstructured":"Costa S, Almeida A, Castro A, Domingues L. Fusion tags for protein solubility, purification, and immunogenicity in Escherichia coli: The novel Fh8 system. Vol. 5, Frontiers in Microbiology. Frontiers Research Foundation; 2014. p. 63.","DOI":"10.3389\/fmicb.2014.00063"},{"key":"10.1016\/j.nano.2021.102445_bb0135","doi-asserted-by":"crossref","unstructured":"Bachmann MF, Jennings GT. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Vol. 10, Nature Reviews Immunology. 2010. p. 787\u201396.","DOI":"10.1038\/nri2868"},{"issue":"31","key":"10.1016\/j.nano.2021.102445_bb0150","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1016\/j.vaccine.2017.05.070","article-title":"Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013","volume":"35","author":"Genito","year":"2017","journal-title":"Vaccine."},{"key":"10.1016\/j.nano.2021.102445_bb0155","doi-asserted-by":"crossref","unstructured":"Casella CR, Mitchell TC. Putting endotoxin to work for us: monophosphoryl lipid a as a safe and effective vaccine adjuvant. Vol. 65, Cellular and Molecular Life Sciences. Springer; 2008. p. 3231\u201340.","DOI":"10.1007\/s00018-008-8228-6"},{"key":"10.1016\/j.nano.2021.102445_bb0160","first-page":"114","article-title":"Mechanisms of action of adjuvants","volume":"4","author":"Awate","year":"2013","journal-title":"Frontiers in immunology. Frontiers"},{"key":"10.1016\/j.nano.2021.102445_bb0165","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jconrel.2017.03.033","article-title":"Synthetic nanovaccines for immunotherapy","volume":"263","author":"Luo","year":"2017","journal-title":"J Control Release."},{"issue":"1","key":"10.1016\/j.nano.2021.102445_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-03798-3","article-title":"Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines","volume":"7","author":"Leneghan","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.nano.2021.102445_bb0180","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.antiviral.2018.06.004","article-title":"MPL and CpG combination adjuvants promote homologous and heterosubtypic cross protection of inactivated split influenza virus vaccine","volume":"156","author":"KO","year":"2018","journal-title":"Antiviral research"},{"key":"10.1016\/j.nano.2021.102445_bb0185","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1128\/iai.65.9.3520-3528.1997","article-title":"Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1","volume":"65","author":"Sasaki","year":"1997","journal-title":"Infect Immun."},{"key":"10.1016\/j.nano.2021.102445_bb0190","doi-asserted-by":"crossref","unstructured":"Eun-Ju Ko, Youri Lee, Young-Tae Lee, Yu-Jin Kim, Ki-Hye Kim, Sang-Moo Kang, MPL and CpG combination adjuvants promote homologous and heterosubtypic cross protection of inactivated split influenza virus vaccine, Antiviral Research, Volume 156, 2018, Pages 107-115, ISSN 0166-3542. Available from: < https:\/\/doi.org\/10.1016\/j.antiviral.2018.06.004 >.","DOI":"10.1016\/j.antiviral.2018.06.004"},{"key":"10.1016\/j.nano.2021.102445_bb0195","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3389\/fimmu.2017.01175","article-title":"Adjuvant-mediated epitope specificity and enhanced neutralizing activity of antibodies targeting dengue virus envelope protein","volume":"8","author":"Maeda","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.nano.2021.102445_bb0200","doi-asserted-by":"crossref","unstructured":"S.N. Slavov, R.R. Guaragna Machado and A.R. Ferreira et al., Zika virus seroprevalence in blood donors from the Northeastern region of S\u00e3o Paulo State, Brazil, between 2015 and 2017, Journal of Infection, https:\/\/doi.org\/10.1016\/j.jinf.2019.10.002.","DOI":"10.1016\/j.jinf.2019.10.002"},{"issue":"7","key":"10.1016\/j.nano.2021.102445_bb0205","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/infdis\/jis033","article-title":"Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection","volume":"205","author":"Kam","year":"2012","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1016\/j.nano.2021.102445_bb0210","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2013-0363","article-title":"Analysis of antibody response (IgM, IgG, IgG3) to Chikungunya virus using panel of peptides derived from envelope protein for serodiagnosis","volume":"52","author":"Verma","year":"2014","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"issue":"22","key":"10.1016\/j.nano.2021.102445_bb0220","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1128\/JVI.01926-14","article-title":"Prime-boost immunization strategies against Chikungunya virus","volume":"88","author":"Halleng\u00e4rd","year":"2014","journal-title":"Journal of virology"},{"key":"10.1016\/j.nano.2021.102445_bb0225","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fcimb.2018.00345","article-title":"Cellular and molecular immune response to chikungunya virus infection","volume":"8","author":"Tanabe","year":"2018","journal-title":"Frontiers in cellular and infection microbiology"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963421000885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963421000885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:16:06Z","timestamp":1761549366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963421000885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":39,"alternative-id":["S1549963421000885"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2021.102445","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2021.102445","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102445"}}